3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Pain
2
Neuralgia
2
Neoplasms
2
Wounds and Injuries
1
Peripheral Nervous System Diseases
1
Pain, Intractable
1
Lymphoma, Follicular
1
HIV Infections
1
Bronchiolitis Obliterans Syndrome
1
Acquired Immunodeficiency Syndrome
1
AIDS-Related Complex
1
Interventions
ibrutinib
9
tofacitinib
7
Imatinib Mesylate
5
ruxolitinib
4
ofatumumab
4
Rituximab
4
Dasatinib
4
nilotinib
3
fludarabine
3
bosutinib
3
asciminib
3
Sirolimus
3
Mycophenolic Acid
3
Cyclophosphamide
3
obinutuzumab
2
Pentostatin
2
Oxycodone
2
Naloxone
2
KW-2478
2
Filgrastim
2
Alemtuzumab
2
ziconotide
1
sodium luminolate
1
posaconazole
1
ponatinib
1
pegfilgrastim
1
oblimersen
1
montelukast
1
mocetinostat
1
milatuzumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Bronchiolitis Obliterans Syndrome
×
ziconotide
×
Clear all
NCT01373983
2014-12-30
ZicBol
University Hospital, Linkoeping
Phase 4
Completed
26 enrolled